MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from moisture. Active substance soluble in water.

Provenance

This compatibility recommendation is derived from Azilect 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from moisture. Active substance soluble in water.

Provenance

This compatibility recommendation is derived from Azilect 1mg tablets (Teva UK Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Stability Notes

No specific storage requirements.

Provenance

This compatibility recommendation is derived from Zithromax 250mg capsules (Pfizer Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.